(Q42546740)

English

Effect of bezafibrate treatment over five years on coronary plaques causing 20% to 50% diameter narrowing (The Bezafibrate Coronary Atherosclerosis Intervention Trial [BECAIT]).

scientific article published on November 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Effect of bezafibrate treatment over five years on coronary plaques causing 20% to 50% diameter narrowing (The Bezafibrate Coronary Atherosclerosis Intervention Trial [BECAIT]). (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

5

object named as

Hamsten A

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

author name string

Ericsson CG

1

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Nilsson J

2

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Grip L

3

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Svane B

4

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

language of work or name

0 references

publication date

1 November 1997

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

80

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

1125-1129

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900626-7

7 January 2021

Coronary Plaque Disruption

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900626-7

7 January 2021

Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900626-7

7 January 2021

Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900626-7

7 January 2021

Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900626-7

7 January 2021

Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900626-7

7 January 2021

The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900626-7

7 January 2021

Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Münster Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900626-7

7 January 2021

ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900626-7

7 January 2021

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900626-7

7 January 2021

Triglyceride-rich lipoproteins and the progression of coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900626-7

7 January 2021

Identifiers

10.1016/S0002-9149(97)00626-7

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42546740&oldid=2145925953"